Atossa Therapeutics
ATOS
#9237
Rank
$0.10 B
Marketcap
$0.80
Share price
5.24%
Change (1 day)
-33.39%
Change (1 year)

Atossa Therapeutics (ATOS) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $6.82 Million USD

According to Atossa Therapeutics's latest financial reports the company's total liabilities are $6.82 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atossa Therapeutics - Total liabilities on balance sheet (from 2010 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$4.96 M-5.14%
2023-12-31$5.23 M-5.96%
2022-12-31$5.56 M78.12%
2021-12-31$3.12 M-80.05%
2020-12-31$15.67 M1074.87%
2019-12-31$1.33 M-54.25%
2018-12-31$2.91 M137.92%
2017-12-31$1.22 M17.01%
2016-12-31$1.04 M-58.14%
2015-12-31$2.5 M10.4%
2014-12-31$2.26 M61%
2013-12-31$1.4 M-14.73%
2012-12-31$1.65 M9.15%
2011-12-31$1.51 M74.44%
2010-12-31$0.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$113.53 B 1,664,694.72%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$9.54 B 139,908.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
$8.82 B 129,240.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
$20.11 M 194.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
$0.53 B 7,766.42%๐Ÿ‡บ๐Ÿ‡ธ USA